Prodia Diagnostic Line is trading at IDR 248, up 3.33%, possibly reflecting broader positive market sentiment and stronger Asian equities.
- No reliable company-specific announcement was identified for August 27, 2026.
- Recent company news remains weak: first-half revenue fell to IDR 13.70 billion, while the company reported an IDR 8.84 billion net loss.
- The stock’s exact intraday volume and activity level were unavailable.